Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma

<div>Kaplan–Meier estimates of overall survival for 94 HCC patients according to RBBP5 expression. (a) RBBP5 was significantly overexpressed in HCC tissues (SP× 400) compared with the adjacent noncancerous tissues (SP× 400). All patients were divided into high (n = 56) and low RBBP5 expression groups (n = 38) according to the score. (b) Patients with high RBBP5 expression had shorter survival times than those with low RBBP5 expression (median survival time: 42.9 months<i> vs.</i> 63.7 months,<i> P</i> &lt; 0.001).</div>

BioMed Research International

fig2

Figure 2

Figure 2: Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma 